Inventor
ARTHUR F. KLUGE
Inventor
US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes19%
PatentTitleYear
12,516,068Protein degraders and uses thereof202612,454,520Protein degraders and uses thereof202512,258,341IRAK degraders and uses thereof202512,168,057IRAK degraders and uses thereof202412,006,329Protein degraders and uses thereof202411,932,635CRBN ligands and uses thereof202411,897,882Tricyclic crbn ligands and uses thereof202411,807,636IRAK degraders and uses thereof202311,723,980IRAK degraders and uses thereof202311,512,080CRBN ligands and uses thereof202211,485,743Protein degraders and uses thereof202211,351,1682,4-disubstituted pyrimidines useful as kinase inhibitors202211,352,350IRAK degraders and uses thereof202211,292,792Tricyclic CRBN ligands and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to KYMERA THERAPEUTICS INC (13)· patent assignee history
2022Patents assigned to CELGENE CAR LLC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KYMERA THERAPEUTICS INC | 13 | 2022–2026 |
| CELGENE CAR LLC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 14 | 2022–2026 |